It is important to validate these interacting proteins as bona fide genetic modifiers, so that they can then be used to provide insight into the normal function of htt in neuronal and non-neuronal cells, and into the molecular pathogenesis of HD. The gene discussed is HTT; the disease is Huntington disease.